Acoustic Wave Cell Therapy, Inc. (AWCT) was founded in 2014 to commercialize a technology platform developed at the University of California, San Francisco (UCSF) by AWCT’s scientific founder, Dr. Tom Lue, and his research team. The research was conducted over 20 years and supported by multiple NIH and DOD grants. Over 65 peer-reviewed scientific articles related to this research have been published. AWCT has exclusive rights to this technology through a license from UCSF. The technology is protected by 21 issued U.S. patents and 9 foreign applications.
AWCT is based in the San Francisco Bay Area and has operations in the Midwest, Southern California, and Taiwan.